Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Harvard Business School
Baxter
Dow
Mallinckrodt

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

PTAB Cases from Par Pharm

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Patent Trial and Appeal Board Cases for Petitioner: Par Pharm

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
5,665,772 Par Pharmaceutical, Inc.   Start Trial 2015-10-26 2015-10-26 COTTENS et al Inter partes review   Start Trial 2016-04-29 SYLVAIN COTTENS   Start Trial
5,665,772 Par Pharmaceutical, Inc.   Start Trial 2016-05-17 2016-05-17 Novartis AG Inter partes review   Start Trial 2016-10-27 SYLVAIN COTTENS   Start Trial
6,455,518 Par Pharmaceutical, Inc.   Start Trial 2015-10-26 2015-10-26 Novartis AG Inter partes review   Start Trial 2016-04-28 Gerhard Zenke   Start Trial
7,297,703 Par Pharmaceutical, Inc.   Start Trial 2015-10-26 2015-10-26 Novartis AG Inter partes review   Start Trial 2016-04-01 Francois Navarro   Start Trial
7,668,730 PAR PHARMACEUTICAL, INC.   Start Trial 2014-07-09 2014-07-09 Jazz Pharmaceuticals, Inc. Covered business method   Start Trial 2015-01-13 Dayton Reardan   Start Trial
7,668,730 PAR PHARMACEUTICAL, INC.   Start Trial 2015-01-08 2015-01-08 Jazz Pharmaceuticals, Inc. Inter partes review   Start Trial 2015-07-28 Dayton Reardan   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Boehringer Ingelheim
Dow
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.